News|Articles|November 14, 2023

Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.

Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Subscribe

Related Content

Ebola virus structure close up (Adobe Stock 1823506847 By Andry)

Latest CME

Video

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Onyema Ogbuagu, MD, FACP, FIDSA; Jeffery A. Goad, PharmD, MPH; William P. Hanage, PhD

Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

Related Content

2026 Ebola Outbreak in DRC and Uganda: GeoVax CEO Warns of Growing Global Preparedness and Vaccine Response Gaps

The Blank Page in the Ebola Playbook: The Ebola Bundibugyo Outbreak in the DRC and Uganda

2026 Ebola Outbreak Spreads Across Central Africa as WHO Warns of Growing Crisis Amid CDC and USAID Cuts

Breaking the Chain of Transmission to Prevent C Auris Infections in Health Care Settings

Hantavirus Outbreak on an Atlantic Cruise Ship: Facts, Figures and Public Health Implications